Sprim Market Share Analysis for February 2026

Sign up to receive the latest news and updates directly in your inbox.

Jobs and Career > Jobs and Employment

Domainsprim.com

Year Founded2001

Employees201 - 500

Annual Revenue$50M - $75M

Sprim

Sprim (including company regionals)

sprim.com

See more website traffic and engagement information

Sprim Revenue up to February 2026 is 50M - 75M

revenue generated by Sprim top domains

Sprim top domains revenue over 3 years

Revenue for Sprim top domains

sprim.com50M - 75M

See more with Sales Intelligence

Total visits to Sprim's top domains

Understand Sprim market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sprim.com3.2K

See more with Sales Intelligence

Avg. visit duration in Sprim's top domains

Analyze Sprim engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sprim.com00:00:05

See more with Sales Intelligence

Avg. pageviews on Sprim's top domains

See how Sprim keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sprim.com1.47

See more with Sales Intelligence

Sprim top competitors by domain

Top similar sites in February 2026, ranked by their affinity

fastdolphin.comCompany NameFast DolphinEmployees51 - 200HQUnited States, Florida, Fort LauderdaleAnnual revenue$10M - $15MTotal visits1KJobs and Career > Jobs and Employment

Top technologies used by Sprim

These are the website technologies, by industry, used by Sprim top domains

Advertising (11)

Google Adsense

Payment & Currencies (4)

Visa

Conversion & Analytics (3)

Google Analytics

Marketing (3)

Google Marketing Platform

More Technologies

11

See all

News & Signals from Sprim

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSPRIM Health Group invested into RheumaGen, Inc. $15M in Series A on Jan 9th '25.AURORA, Colo., Jan. 9, 2025 /PRNewswire/ - RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, announced today the close of a $15 million Series A financing co-led by SPRIM Global Investments and William Taylor Nominees.

NewsSPRIM Health Group invests into Prota Therapeutics Pty Ltd $21M.Singapore's SPRIM Global anchors $21m funding in australia's Prota Therapeutics.

NewsSPRIM Health Group invests into VCTC Ltd.VCTC, a Derby, UK-based company which specializes in clinical trial site, received an equity investment from Sprim Global Investments.